E-LIB Suche - Ergebnisse für: Verhaak, Roel

1

Oncogenic composite mutations can be predicted by co‐mutati..:

Küçükosmanoglu, Asli ; van der Borden, Carolien L. ; de Boer, Lisanne E. A....
Molecular Oncology. , 2024

Link: https://doi.org/10.1002/..

2

[18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TR..:

Koh, Eng-Siew ; Gan, Hui K ; Senko, Clare...
BMJ Open. 13 (2023) 8 - p. e071327 , 2023

Link: https://doi.org/10.1136/..

3

CTNI-23. SINGLE CELL TRANSCRIPTOMICS, PHARMACOKINETICS, AND..:

Johnson, Kevin ; Tien, An-Chi ; Jiang, Jun...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v78-v79 , 2023

Link: https://doi.org/10.1093/..

4

QOL-09. QUALITY OF LIFE AFTER SURGERY FOR LOWER GRADE GLIOM..:

Heffernan, Anne ; Wu, Yilun ; Benz, Luke...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v250-v250 , 2023

Link: https://doi.org/10.1093/..

5

NIMG-23. COMBINATION OF ADC MRI AND FET PET FOR THE ASSESSM..:

Tjin Joe, Kaithlyn Tjong ; Wesseling, Pieter ; Barkhof, Frederik...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v190-v190 , 2023

Link: https://doi.org/10.1093/..

6

EPCO-34. IMAGE-BASED PHENOTYPIC HIGH-CONTENT CRISPR-CAS9 SC..:

Amin, Samir ; Gujar, Amit ; Yi, Eunhee...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v131-v131 , 2023

Link: https://doi.org/10.1093/..

7

DISP-10. ENHANCING TRUST AND REPRESENTATIVE PARTICIPATION I..:

Salmi, Liz ; Barnard, Juliana ; Ritger, Carly...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v138-v139 , 2023

Link: https://doi.org/10.1093/..

8

Correcting the drug development paradigm for glioblastoma r..:

Singh, Kirit ; Hotchkiss, Kelly M. ; Parney, Ian F....
Nature Medicine. 29 (2023) 10 - p. 2402-2405 , 2023

Link: https://doi.org/10.1038/..

9

DISP-04. EXPLORING ENGAGEMENT IN LOW GRADE GLIOMA GENOMIC R..:

Kwan, Bethany ; Barnard, Juliana ; Ritger, Carly...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v137-v137 , 2023

Link: https://doi.org/10.1093/..

10

TMIC-10. IDENTIFICATION, VALIDATION AND BIOLOGICAL CHARACTE..:

White, Kieron ; Connor, Kate ; Meylan, Maxime...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii273-vii273 , 2022

Link: https://doi.org/10.1093/..

11

EPCO-13. IDENTIFYING REGULATORS OF GLIOMA CELL STATE DIVERS..:

Johnson, Kevin ; Anderson, Kevin ; Nehar-Belaid, Djamel...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii118-vii118 , 2022

Link: https://doi.org/10.1093/..

12

Central nervous system immune interactome is a function of ..:

Najem, Hinda ; Ott, Martina ; Kassab, Cynthia...
JCI Insight. 7 (2022) 9 - p. , 2022

Link: https://doi.org/10.1172/..

13

CTIM-24. NUTMEG: A RANDOMIZED PHASE II STUDY OF NIVOLUMAB A..:

Sim, Hao-Wen ; Lwin, Zarnie ; Barnes, Elizabeth...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii65-vii65 , 2022

Link: https://doi.org/10.1093/..

14

PATH-11. THE LONGITUDINAL EVOLUTIONARY TRAJECTORY OF OLIGOD..:

Varn, Frederick ; Ye, Gordon ; Ghospurkar, Padmaja...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii152-vii152 , 2022

Link: https://doi.org/10.1093/..

15

OTEH-10. Evolutionary trajectory of epigenomic of gliomas:

Malta, Tathiane ; Sabedot, Thais ; Datta, Indrani...
Neuro-Oncology Advances. 3 (2021) Supplement_2 - p. ii12-ii12 , 2021

Link: https://doi.org/10.1093/..